Harvard 4th Annual Update In Neuro-Oncology 2024

Harvard 4th Annual Update In Neuro-Oncology 2024

+ Include:  videos +  pdf, size:  GB

Course Audience: neurologists, oncologists

Overview:

Neuro-oncology is a rapidly evolving multi-disciplinary field, which involves the medical, radiation, and surgical management of pediatric and adult patients with primary and metastatic tumors of the central nervous system (CNS) and peripheral nervous system (PNS). In addition, modern molecular neuropathology and neuroradiology concepts are essential for accurate diagnosis and classification. This three-day CME course, Annual Update in Neuro-Oncology, is designed to provide an international audience with a comprehensive review of the diagnosis and management of pediatric and adult patients with primary and metastatic CNS and PNS tumors and neurological complications of cancer. Our target audience will be the providers involved in the care of adult and pediatric neuro-oncology patients (oncologists, radiation oncologists, neurosurgeons, neurologists, neuroradiologists, and neuropathologists). The course will also be of high relevance to nurse practitioners, physician assistants, psychologists, pharmacists, and nurses.

Who Should Attend

• Specialty Physicians
• Physician Assistants
• Nurses
• Pharmacists
• Psychologists

Learning Objectives

Upon completion of this activity, participants will be able to:

• Define the role of molecular biomarkers in the accurate diagnosis and classification of pediatric and adult CNS and PNS tumors.
• Determine standard and novel treatment approaches to pediatric and adult CNS and PNS tumors.
• Recognize and manage neurological complications associated with new cancer therapies.
• Identify and manage long-term complications of CNS and PNS tumors and their treatment.

 

Wednesday, July 24, 2024

Day One

10:00-10:10 AM

Welcome: Pediatric Neuro-Oncology Session

Scott Pomeroy, MD, PhD

10:10-10:25 AM

Keynote: Targeted Therapy for Pediatric Low-Grade Glioma

Karen Wright, MD

10:25-10:40 AM

WHO Classification, Pediatric CNS Tumors

Sanda Alexandrescu, MD

10:40-11:10 AM

Advances in the Imaging of Pediatric Brain Tumors

Tina Young Poussaint, MD, FACR

11:10-11:40 AM

Embryonal Tumors

Scott Pomeroy, MD, PhD

11:40 AM-12:00 PM

Break

12:00-12:30 PM

Pediatric Low-Grade Gliomas

Susan Chi, MD

12:30-1:00 PM

Pediatric High-Grade Gliomas

Mariella Filbin, MD, PhD

1:00-1:15 PM

Ependymomas

Pratiti Bandopadhayay, MBBS, PhD

1:15-1:45 PM

Live Q&A Session

Scott Pomeroy, MD, PhD

1:45-2:00 PM

Break

2:00-2:15 PM

Choroid Plexus Tumors

Viviana Benitez, MD

2:15-2:30 PM

Pineal Tumors

Shannon MacDonald, MD

2:30-2:45 PM

Germ Cell Tumors

Kee Kiat Yeo, MD

2:45-3:15 PM

Neurofibromatosis

Scott Plotkin, MD, PhD

3:15-3:30 PM

Von Hippel Lindau

Othon Iliopoulos, MD

3:30-3:45 PM

Live Q&A Session

Scott Pomeroy, MD, PhD

Thursday, July 25, 2024

Day Two

10:00-10:05 AM

Welcome: Adult Neuro-Oncology

Bob Carter, MD, PhD

10:05-10:30 AM

Keynote: CAR-T Cell Therapy for Glioblatoma

Bryan Choi, MD, PhD

10:30-10:45 AM

Advances in Surgery for Brain Tumors

E. Antonio Chiocca, MD, PhD

10:45-11:00 AM

Advances in Imaging for Brain Tumors

Pamela Schaefer, MD, FACR

11:00-11:15 AM

Advances in Radiation for Brain Tumors

Helen Shih, MD

11:15-11:25 AM

Live Question and Answer Session

Bob Carter, MD, PhD

11:25-11:30 AM

Break

11:30 AM-12:00 PM

WHO Classification for Adult Gliomas

Maria Martinez—Lage Alvarez, MD

12:00-12:30 PM

Gliomas, IDH-Mutant

​​​​​Nicolas Gonzalez Castro, MD, PhD

12:30-12:45 PM

Gliomas, IDH-Wildtype

Isabel Arrillaga-Romany, MD, PhD

12:45-1:15 PM

Advances in Experimental Therapies for Gliomas

David Reardon, MD

1:15-1:30 PM

Break

1:30-1:45 PM

Meningioma

Wenya Linda Bi, MD, PhD

1:45-2:00 PM

CNS Lymphomas

Tracy Batchelor, MD, MPH

2:00-2:15 PM

Pituitary Tumors

Pamela Jones, MD

2:15-2:45 PM

Live Question & Answer Session

Bob Carter, MD, PhD

2:45-2:50 PM

Adjourn

Bob Carter, MD, PhD

Friday, July 26, 2024

Day Three

10:00-10:05 AM

Welcome: Neurological Complications of Cancer

Patrick Wen, MD

10:05-10:30 AM

Keynote: The Oncogenic Origins of Temporal Lobe Epilepsy

Sattar Khoshkhoo, MD

10:30-11:00 AM

Metastases to the Brain

Priscilla Brastianos, MD

11:00-11:15 AM

Metastases to the Leptomeninges

Jose Ricardo McFaline-Figueroa, MD, PhD

11:15-11:30 AM

Metastases to the Epidural Space and Spinal Cord

John Chi, MD, MPH

11:30-11:45 AM

Live Question and Answer Session

Patrick Wen, MD

11:45 AM-12:15 PM

Break

12:15-12:30 PM

Paraneoplastic Neurological Syndromes

Eudocia Lee, MD, MPH

12:30-1:00 PM

Common Neurological Complications in Cancer Patients

Nancy Wang, MD

1:00-1:15 PM

Neurological Complications of Cancer Immunotherapies

Jorg Dietrich, MD, PhD

1:15-1:30 PM

Managing Long-Term Survivors of CNS Tumors

Deborah Forst, MD

1:30-1:45 PM

The Role of the Neuropsychologist in Neuro-Oncology

Michael Parsons, PhD, ABPP

1:45-2:00 PM

Live Question and Answer Session

Patrick Wen, MD

2:00-2:15 PM

Closing Statements

Tracy Batchelor, MD, MPH